NEW YORK, NY — As the sun sets on October 13, 2026, the global skyline will undergo a dramatic transformation. From the towering heights of One World Trade Center in Manhattan to the mist-covered cascades of Niagara Falls, more than 325 iconic landmarks across 50 U.S. states and 20 countries will be bathed in a specific tri-color palette of teal, green, and pink.
This coordinated display is not merely aesthetic; it is the visual heartbeat of #LightUpMBC, a global campaign spearheaded by METAvivor Research and Support. The initiative aims to cast a blinding light on a stark reality often lost in the "pink-ribbon" messaging of October’s Breast Cancer Awareness Month: the reality of Metastatic Breast Cancer (MBC), also known as Stage 4.
While early-stage breast cancer awareness focuses heavily on detection and the "completion" of treatment, the #LightUpMBC campaign seeks to pivot the conversation toward the estimated 42,670 Americans expected to die from the disease in 2026. For these patients, there is no "finishing" treatment—only the hope that research will stay one step ahead of the cancer’s progression.
Main Facts: Turning Awareness into Actionable Research
The #LightUpMBC campaign serves as the primary fundraising and awareness engine for METAvivor, the only national organization in the United States dedicated exclusively to funding research for Stage 4 metastatic breast cancer. Unlike other initiatives that spread funds across screening and early-stage education, METAvivor directs 100% of its net proceeds toward scientific grants aimed at extending the lives of those already diagnosed with terminal disease.
The October 13 event coincides with National Metastatic Breast Cancer Awareness Day. The scale of the 2026 campaign is unprecedented, involving 195 cities worldwide. Beyond the physical illumination of landmarks, the centerpiece of the evening is "#LightUpMBC Live," a virtual broadcast that bridges the gap between patient advocacy, scientific innovation, and the arts.
The campaign’s color scheme is deeply symbolic. While pink represents the traditional breast cancer movement, the addition of teal symbolizes healing and hope, while green represents the triumph of spring over winter—signifying the renewal of life. Together, they represent the unique journey of the metastatic patient: a life lived in the shadow of a terminal diagnosis but fueled by the tenacity of hope.
Chronology: From a Single Bridge to a Global Phenomenon
The origins of #LightUpMBC are rooted in a story of personal loss and a modest wish. In 2017, the movement began with a single landmark: the Memorial Bridge in Portsmouth, New Hampshire. It was the vision of Jessica Moore, a young woman diagnosed with MBC who hoped to see one local landmark lit in the MBC colors to help people understand that her disease was different from the curable stages of breast cancer.
Jessica Moore passed away at the age of 36, but her legacy was codified by her best friend, Laura Inahara. Since that first bridge flickered to life in 2017, the campaign has seen exponential growth:
- 2017–2019: The movement spread across the Northeastern United States, primarily through grassroots efforts by MBC patients and their families.
- 2020: Despite the global pandemic, the campaign transitioned to a digital-first model, launching the inaugural #LightUpMBC Live stream, which allowed the movement to go international.
- 2021–2025: The number of participating landmarks grew from dozens to hundreds. Major international hubs like Mactan-Cebu Airport in the Philippines and Ness Bridge in Scotland joined the roster, signaling a shift in global medical advocacy.
- 2026: The current campaign marks a record-breaking year with over 325 landmarks. To date, the initiative has raised over $2.7 million specifically for MBC research, a figure expected to climb significantly following the October 13 events.
Supporting Data: The Biological and Statistical Reality of MBC
To understand the urgency of the #LightUpMBC campaign, one must look at the sobering statistics provided by the National Cancer Institute and the SEER (Surveillance, Epidemiology, and End Results) program.
The Mortality Gap
In 2026, it is projected that approximately 117 people will die every single day from breast cancer in the United States alone. Despite the ubiquity of pink ribbons, breast cancer remains the leading cause of cancer death among women aged 20 to 59. Crucially, 100% of these deaths are the result of metastasis—the spread of the cancer from the breast to vital organs such as the bones, liver, lungs, or brain.
The Staging Misconception
Metastatic breast cancer is often misunderstood by the general public. It is not a new cancer when it appears in the lungs; it is breast cancer cells that have migrated. Data shows that:
- Approximately 6% of new breast cancer diagnoses are "de novo," meaning the cancer is already Stage 4 at the time of initial discovery.
- Nearly 30% of women diagnosed with early-stage breast cancer will eventually see their disease progress to Stage 4, sometimes decades after being told they were "cancer-free."
The Funding Disparity
Historically, only a small fraction of overall breast cancer research funding (estimated between 2% and 5%) has been dedicated to metastatic disease. The majority of funding is directed toward prevention and early detection. METAvivor was founded to correct this imbalance, operating on the principle that while prevention is vital, those already dying from the disease cannot be abandoned by the scientific community.
Official Responses: Voices from the Frontlines
The leadership of METAvivor and the creators of the #LightUpMBC campaign emphasize that the event is as much about community as it is about capital.
Dr. Kelly Shanahan, a physician and the METAvivor Board President, provides a unique perspective as both a medical professional and a patient. Diagnosed with MBC in 2013, her survival for 13 years is a testament to the very research the organization funds.
“When I was diagnosed, I certainly didn’t think I’d still be here 13 years later,” Dr. Shanahan stated. “My hope, and the hope of so many others, lies in research. METAvivor-funded research is increasingly important these days as we look for the next generation of targeted therapies. #LightUpMBC is the biggest contributor to this research, and is also a way to bring us together as a community.”
Laura Inahara, the founder of the campaign, reflects on the exponential growth of Jessica Moore’s original dream. “Jessica hoped to illuminate one local landmark. Today, her legacy helps families around the world shine a light for the people they love,” Inahara said. “It has taught patients with MBC how to advocate for themselves and has now raised over $2.7 million for critical research.”
The 2026 live broadcast will be hosted by Tami Eagle Bowling, an 11-year MBC survivor and the campaign’s director, alongside Broadway star Kara Lindsay. Bowling emphasizes the educational component of the night: “We aren’t just lighting buildings; we are sharing the stories behind the lights. We are bringing together the world’s leading scientific minds and the patients whose lives depend on their next discovery.”
Implications: Changing the Narrative of a Terminal Diagnosis
The #LightUpMBC campaign is a bellwether for a broader shift in oncology and patient advocacy. By focusing on the "Stage 4" experience, the movement is successfully challenging the "warrior" and "survivor" tropes that can often alienate those with terminal diagnoses.
From Terminal to Chronic
The ultimate goal of METAvivor is to transform MBC from a terminal illness into a manageable chronic condition, similar to HIV/AIDS or Type 1 Diabetes. The implications of the $2.7 million raised thus far are seen in the development of PARP inhibitors, antibody-drug conjugates (ADCs), and personalized immunotherapy—treatments that were once experimental but are now extending lives.
The Power of Global Advocacy
The participation of landmarks like the Willis Tower in Chicago and the Philadelphia City Hall signals a corporate and civic recognition of the MBC community. This visibility pressures policy-makers to prioritize research funding and ensures that the "Stage 4" community is no longer a "silent" segment of the breast cancer population.
Public Engagement
The campaign also leverages the power of social media to democratize advocacy. By encouraging the public to photograph landmarks and share them with the hashtag #LightUpMBC, the movement creates a digital archive of support. This visibility is crucial for patients who often feel isolated by the "positive-only" messaging of mainstream awareness campaigns.
As the lights dim on the morning of October 14, the work of METAvivor will continue. The funds raised during this global event will be funneled into the next cycle of research grants, vetted by a rigorous process that includes both scientific peers and patient advocates. For the thousands of people living with MBC, these lights are more than a tribute—they are a promise that the world is finally looking at the reality of the disease, and more importantly, doing something to change it.
How to Participate:
- Watch: #LightUpMBC Live streams on October 13 at 8 p.m. ET via METAvivor’s YouTube and Facebook channels.
- Engage: Post photos of illuminated landmarks using #LightUpMBC and #METAvivor.
- Donate: 100% of net proceeds fund MBC research at www.lightupmbc.org.
About the Author
